Insulin Delivery Devices - Medical Devices Pipeline Assessment, 2019

1.1 List of Tables
1.2 List of Figures

2.1 Insulin Delivery Devices Overview

3.1 Insulin Delivery Devices - Pipeline Products by Stage of Development
3.2 Insulin Delivery Devices - Pipeline Products by Segment
3.3 Insulin Delivery Devices - Pipeline Products by Territory
3.4 Insulin Delivery Devices - Pipeline Products by Regulatory Path
3.5 Insulin Delivery Devices - Pipeline Products by Estimated Approval Date
3.6 Insulin Delivery Devices - Ongoing Clinical Trials

4.1 Insulin Delivery Devices Companies - Pipeline Products by Stage of Development
4.2 Insulin Delivery Devices - Pipeline Products by Stage of Development

5.1 Amrita Vishwa Vidyapeetham Company Overview
5.2 Andain, Inc Company Overview
5.3 Animas Corp Company Overview
5.4 ASTI Corp Company Overview
5.5 Avecho Biotechnology Ltd Company Overview
5.6 Becton Dickinson and Co Company Overview
5.7 Bigfoot Biomedical Inc Company Overview
5.8 Biocon Ltd Company Overview
5.9 Cam Med LLC Company Overview
5.10 Cambridge Consultants Ltd Company Overview
5.11 Capillary Biomedical, Inc. Company Overview
5.12 Cellnovo Ltd Company Overview
5.13 CeQur SA Company Overview
5.14 Companion Medical Inc Company Overview
5.15 Dance Biopharm Inc Company Overview
5.16 Debiotech SA Company Overview
5.17 Defymed SAS Company Overview
5.18 Dermisonics Inc (Inactive) Company Overview
5.19 Eli Lilly and Co Company Overview
5.20 Emperra GmbH E-Health Technologies Company Overview
5.21 Hospira Inc Company Overview
5.22 Imagine Medical Device Inc. Company Overview
5.23 InsuLenz Company Overview
5.24 Insulet Corp Company Overview
5.25 InsuLine Medical Ltd Company Overview
5.26 Iowa State University Company Overview
5.27 LifeScan Inc Company Overview
5.28 MannKind Corp Company Overview
5.29 Medical International Technologies (Mit Canada) Inc Company Overview
5.30 MedPro Safety Products, Inc. Company Overview
5.31 MedSolve Technologies, Inc. Company Overview
5.32 Medtronic Diabetes Company Overview
5.33 Medtronic plc Company Overview
5.34 MicroPort Scientific Corp Company Overview
5.35 NanoDerma Ltd Company Overview
5.36 Nitto Denko Corp Company Overview
5.37 North Carolina State University Company Overview
5.38 Novo Nordisk AS Company Overview
5.39 Pennsylvania State University Company Overview
5.40 Phluid Corporation Company Overview
5.41 Prometheon Pharma LLC Company Overview
5.42 Sanofi Company Overview
5.43 SFC Fluidics LLC Company Overview
5.44 Spring Health Solutions Ltd. Company Overview
5.45 Tandem Diabetes Care Inc Company Overview
5.46 Terumo Corp Company Overview
5.47 Thermalin Inc Company Overview
5.48 Transdermal Specialties Inc Company Overview
5.49 University of KwaZulu-Natal Company Overview
5.50 University of Missouri-Kansas City Company Overview
5.51 University of North Carolina Company Overview
5.52 University of Toronto Company Overview
5.53 Univlabs Technologies Pvt Ltd Company Overview
5.54 Valeritas Inc Company Overview
5.55 ViCentra BV Company Overview
5.56 Vigmed Holding AB Company Overview
5.57 WaveForm Technologies Inc Company Overview
5.58 Ypsomed Holding AG Company Overview
5.59 Zealand Pharma AS Company Overview

6.1 Jun 25, 2019: ConvaTec Group: Board Change
6.2 Jun 17, 2019: Xeris Pharmaceuticals announces additional positive outcomes from a global phase 3 clinical trial of its investigational ready-to-use glucagon
6.3 Jun 17, 2019: BD announces new leadership for BD Biosciences
6.4 Jun 14, 2019: Biocon Biologics facilities In Bengaluru receive EU GMP Certification
6.5 Jun 14, 2019: Drug Makers Sue to Block requirement for Listing Prices in TV Ads
6.6 Jun 11, 2019: Zealand Pharma presents dasiglucagon pivotal Phase 3 trial data at the 79th Scientific Sessions of the American Diabetes Association (ADA)
6.7 Jun 11, 2019: Changes in Roche's board of directors and corporate executive committee
6.8 Jun 11, 2019: Regulators demand more details on Roche’s $4.8bn Spark acquisition
6.9 Jun 10, 2019: Valeritas V-Go Wearable Insulin Delivery Device demonstrates a reduction in A1c levels by 1.3 when intensifying from a basal insulin regimen to basal-bolus delivery
6.10 Jun 09, 2019: MannKind Presents Positive Afrezza Clinical Data from Three Studies at ADA 79th Scientific Sessions
6.11 Jun 07, 2019: Companion Medical announces product updates to support data partnerships and enhanced reporting
6.12 Jun 07, 2019: Paul Hudson to succeed Olivier Brandicourt as chief executive officer
6.13 Jun 06, 2019: Dexcom and Companion Medical announce collaboration to integrate Dexcom CGM data and InPen insulin data
6.14 Jun 06, 2019: Insulet to showcase its recently-lunched Omnipod DASH System and present seven scientific abstracts at the American Diabetes Association's 79th Scientific Sessions
6.15 Jun 05, 2019: CeQur appoints Bradley Paddock Chief Executive Officer
6.16 Jun 05, 2019: Companion Medical and Glooko announce partnership agreement to integrate insulin data for multiple daily injections
6.17 Jun 05, 2019: Jeff Settleman, Ph.D., joins Pfizer to lead oncology research & development
6.18 Jun 04, 2019: Rimidi and Companion Medical announce first U.S. partnership to bring connected Insulin data Into the clinical workflow
6.19 Jun 04, 2019: Medtronic awarded $150M contract from Defense Logistics Agency
6.20 Jun 03, 2019: Afrezza (insulin human) inhalation powder approved in Brazil

7.1 Methodology
7.2 About the Author
7.3 Contact Us
7.4 Disclaimer

Table 1: Insulin Delivery Devices - Pipeline Products by Stage of Development
Table 2: Insulin Delivery Devices - Pipeline Products by Segment
Table 3: Insulin Delivery Devices - Pipeline Products by Territory
Table 4: Insulin Delivery Devices - Pipeline Products by Regulatory Path
Table 5: Insulin Delivery Devices - Pipeline Products by Estimated Approval Date
Table 6: Insulin Delivery Devices - Ongoing Clinical Trials
Table 7: Insulin Delivery Devices Companies - Pipeline Products by Stage of Development
Table 8: Insulin Delivery Devices - Pipeline Products by Stage of Development
Table 9: Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Amrita Insulin Pump - Product Status
Table 11: Amrita Insulin Pump - Product Description
Table 12: Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Gaia Med Diamond Semi-Disposable Pump - Product Status
Table 14: Gaia Med Diamond Semi-Disposable Pump - Product Description
Table 15: Gemini Pump - Product Status
Table 16: Gemini Pump - Product Description
Table 17: Animas Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Hypoglycemia-Hyperglycemia Minimizer System - Product Status
Table 19: Hypoglycemia-Hyperglycemia Minimizer System - Product Description
Table 20: ASTI Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Medical Microneedle System - Product Status
Table 22: Medical Microneedle System - Product Description
Table 23: Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 24: TPM-Insulin Patch - Product Status
Table 25: TPM-Insulin Patch - Product Description
Table 26: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 27: BD Vystra Disposable Pen - Product Status
Table 28: BD Vystra Disposable Pen - Product Description
Table 29: Extended Wear Insulin Infusion Set - Product Status
Table 30: Extended Wear Insulin Infusion Set - Product Description
Table 31: Type 2 Patch Pump - Product Status
Table 32: Type 2 Patch Pump - Product Description
Table 33: Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Bigfoot Inject - Product Status
Table 35: Bigfoot Inject - Product Description
Table 36: Smartloop Integrated With FreeStyle Libre Glucose Monitoring System - Product Status
Table 37: Smartloop Integrated With FreeStyle Libre Glucose Monitoring System - Product Description
Table 38: Biocon Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Semglee Prefilled Pen - Product Status
Table 40: Semglee Prefilled Pen - Product Description
Table 41: Cam Med LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Evopump - Product Status
Table 43: Evopump - Product Description
Table 44: Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 45: KiCoPen - Product Status
Table 46: KiCoPen - Product Description
Table 47: Capillary Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 48: CSII Catheter - Product Status
Table 49: CSII Catheter - Product Description
Table 50: Capillary Biomedical, Inc. - Ongoing Clinical Trials Overview

Figure 1: Insulin Delivery Devices - Pipeline Products by Stage of Development
Figure 2: Insulin Delivery Devices - Pipeline Products by Segment
Figure 3: Insulin Delivery Devices - Pipeline Products by Territory
Figure 4: Insulin Delivery Devices - Pipeline Products by Regulatory Path
Figure 5: Insulin Delivery Devices - Pipeline Products by Estimated Approval Date
Figure 6: Insulin Delivery Devices - Ongoing Clinical Trials